Application 213998
- Type
- ANDA
- Sponsor
- CAPLIN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SUMATRIPTAN SUCCINATE | SUMATRIPTAN SUCCINATE | INJECTABLE;SUBCUTANEOUS | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 65145-118 | Sumatriptan | Sumatriptan | Caplin Steriles Limited | ANDA | Current |
| 70069-804 | Sumatriptan | Sumatriptan | Somerset Therapeutics, LLC | ANDA | Current |
| 70594-068 | Sumatriptan | SUMATRIPTAN SUCCINATE | Xellia Pharmaceuticals USA LLC | ANDA | Current |